Industry News
Related Searches:
Filter by:
1201 - 1215 of 2385 results
Prev
79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159
Next
December 28, 2009
Lilly and Kowa Pharmaceuticals America, a subsidiary of Kowa Co., Ltd., have entered into a co-promotion agreement to commercialize Livalo (pitavastatin) in the U.S. and entered into a licensing agreement in Latin America.
Read More »
December 28, 2009
Teva-KOWA Pharma Co., Ltd. has signed a definitive agreement to acquire a majority (at least 66.7%) of the outstanding shares of Taisho Pharmaceutical Industries, Ltd.
Read More »
December 28, 2009
The United States District Court in Boston has entered final judgment ending the five-year patent infringement dispute between Amgen and Roche.
Read More »
December 22, 2009
Sanofi builds U.S. OTC presence with $1.9 billion buy.
Read More »
December 22, 2009
Durata scquires Pfizer unit for antibiotic candidate.
Read More »
December 16, 2009
Hospira will acquire the generic injectable finished-dosage form pharmaceuticals business of India-based Orchid for $400 million.
Read More »
December 16, 2009
Covance has opened new clinical development offices in Seoul and Mumbai and has expanded offices in Tokyo and Hong Kong
Read More »
December 15, 2009
Patheon has successfully released the first commercial shipments of Zogenix's Sumavel DosePro
Read More »
December 15, 2009
Abbott will acquire STARLIMS for $123 million.
Read More »
December 14, 2009
ICON has expanded its European Central Laboratory.
Read More »
December 14, 2009
Cubist may spend as much as $400 million on Calixa.
Read More »
December 10, 2009
Patheon will consolidate PR operations into Manati site, either losing or selling Caguas plant.
Read More »
December 9, 2009
Particle Sciences has expanded its HPC handling capabilities with help from IES Engineers.
Read More »
December 7, 2009
Celgene Corporation will acquire Gloucester Pharmaceuticals for $340 million in cash and as much as $300 million in milestone payments.
Read More »
December 3, 2009
Shri Thanedar, Ph.D., has been named chief executive officer of Azopharma Product Development Group.
Read More »
1201 - 1215 of 2385 results
Prev
79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159
Next



